30
Jan

Aveo Oncology and Astellas Pharma are shutting down a Phase II study of tivozanib in breast cancer after failing to enroll enough patients, the partners announced.

…read more

Source: Aveo’s cancer drug circles the drain after a scuttled Phase II trial

    

0 No comments